FindTrial
Sign In

To study whether giving long duration prophylactic antibiotics in patients with isolated blunt chest injuries managed with intercostal tube drainage (ICD) has any role in preventing ICD related infectious complications.

To study the role of prophylactic antibiotics in patients with chest trauma at a level 1 Trauma Centre: A pilot randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021704
Enrollment
90
Registered
2019-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J958- Other intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified

Interventions

Intervention1: No antibiotics: Antibiotics shall be withrawn in intervention group Intervention2: No antibiotics: No antibiotics shall be given in intervention group Control Intervention1: Amoxycillin

Sponsors

Department of Trauma surgery
Lead Sponsor
Asst Prof Dr Abhinav Kumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age - 15 years and above. 2. Patients with Isolated blunt chest trauma requiring closed tube thoracostomy.

Exclusion criteria

Exclusion criteria: 1. Penetrating chest injuries. 2. Associated injuries requiring antibiotic administration. 3. Patient requiring ventilator support. 4. Known pulmonary disease/ Immuno-compromised patients. 5. Patient with chest trauma requiring open thoracotomy. 6. Those already on antibiotics for some other injuries/illness. 7. Patients who will not give consent.

Design outcomes

Primary

MeasureTime frame
To study the infectious complication rate in patients of Isolated blunt trauma chest managed with ICD i.e. pmeumonia/empyema/peritubal SSI between two groups: one with prolong prophylactic antibiotics and the other without prolong prophylactic antibioticsTimepoint: once ICD is removed/ICD related infectious complications—

Secondary

MeasureTime frame
To compare the rate of infectious complications rate between these two groupsTimepoint: Till ICD is in situ in both groups—

Countries

India

Contacts

Public ContactDr Takio Teyi

AIIMS, New Delhi

subodh6@gmail.com9810202776

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026